Summary

Companies like GW Pharmaceuticals has already established licensing with pharma companies abroad.

There still has yet to be a mass appeal for state side interest in the Life Sciences segment of medical marijuana.

GrowBLOX grow chamber recently arrived in Las Vegas allowing GBLX to officially cultivate a consistent medical grade product which could appeal in a similar way as GWPH.

There's opportunity for emerging companies to become acquisition or licensing targets for Big Pharma to come in within the near future as popular opinion shifts in support of alternative medicine.